1. Serological detection of hepatitis B and D virus co-infection among patients attending a tertiary health facility at Maiduguri, Nigeria
- Author
-
Iman U. Igwegbe, Bamidele Soji Oderinde, Joshua Dawurung, Oyebode O. Samuel, Semsari Latbone, Hamidu M. Ibrahim, Ballah Akawu Danue, Babagana W. Goni, Babajide Ajayi, Ibrahim Musa Kida, and Idris Nasir Abdullahi
- Subjects
HBsAg ,medicine.medical_specialty ,lcsh:Internal medicine ,Cirrhosis ,HDV-HBV co-infection ,viruses ,Seroprevalence ,Nigeria ,medicine.disease_cause ,Hepatitis D virus ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,030212 general & internal medicine ,lcsh:RC31-1245 ,Hepatitis B virus ,business.industry ,virus diseases ,Hepatitis B ,biochemical phenomena, metabolism, and nutrition ,medicine.disease ,digestive system diseases ,HBeAg ,030211 gastroenterology & hepatology ,Liver function ,business - Abstract
Background Hepatitis D virus (HDV) is highly pathogenic, and clinical studies revealed that HDV infection aggravates the natural history of the underlying hepatitis B virus (HBV) infection by progression to cirrhosis that leads to early decompensation of liver function compared with HBV mono-infection. To determine the seroprevalence of HDV among HBsAg-seropositive patients and associated biochemical profiles at Maiduguri, Nigeria, a hospital-based cross-sectional study on 180 sera of patients positive for HBsAg by ELISA were evaluated for anti-HDV, hepatitis B envelop antigen, anti-HBs antibodies and liver enzyme profiles. Results HDV seroprevalence of 3.3% among 180 HBsAg-positive patients. Relatively higher seroprevalence of HDV was observed in males (4.3%) than in females (2.3%). The highest infection rate (20%) was obtained in patients ≥ 56 years. However, no significant association between positive anti-HDV seroprevalence and gender (p > 0.05). Of the 6 (3.3%) anti-HDV-positive patients, only 1 (16.7%) was positive for HBeAg while all were negative for anti-HBs antibodies. The mean level of liver enzyme level of AST and ALT of the anti-HDV-positive patients significantly differ from that of HBsAg mono-infected patients (p ˂ 0.05). However, no significant difference (p p ˃ 0.05) was found. Conclusion This study revealed a relatively low presence of HDV in HBsAg-positive patients. Furthermore, HDV-HBV co-infected patients had somewhat worse liver enzyme upregulation. This underscores the need for rapid HDV testing and treatment in HBV-infected patients.
- Published
- 2021